Podcasts about pfe

12 Articles With Great ESG Stock Picks. Includes the terrific Humankind ranking, top infrastructure, lithium mining, and AI stock picks. By Ron Robins, MBA Transcript & Links, Episode 157, July 25, 2025 Hello, Ron Robins here. Welcome to my podcast episode 157, published on July 25, 2025, titled “12 Articles With Great ESG Stock Picks.” Before I begin, I want to let you know that my next podcast will be on August 22nd as I'm taking some time off. So, this podcast is presented by Investing for the Soul. Investingforthesoul.com is your go-to site for vital global, ethical, and sustainable investing mentoring, news, commentary, information, and resources. Remember that you can find a full transcript and links to content, including stock symbols and bonus material, on this episode's podcast page at investingforthesoul.com/podcasts. Also, a reminder. I do not evaluate any of the stocks or funds mentioned in these podcasts, and I don't receive any compensation from anyone covered in these podcasts. Furthermore, I will reveal any investments I have in the investments mentioned herein. Additionally, please visit this podcast's webpage for links to the articles and additional company and stock information. I have a great crop of 12 articles for you in this podcast! Note that some companies are mentioned more than once! ------------------------------------------------------------- Humankind 100 rankings I'm beginning this episode with another of my favourite company rankings whose annual list has just been released. It's the Humankind 100 rankings. Here is an overview of them from their website. “The Humankind 100 celebrates the one hundred U.S. public companies with the highest Humankind Values. We believe these companies consistently work to create large amounts of value, not just for their investors, but for humanity at large. The Humankind 100 companies are ranked based on Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large, and are therefore among the most ethical companies in the United States, according to our research.” End quotes. Their top 5 companies are Alphabet Inc. (GOOGL), Eli Lilly & Company (1LLY.MI), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), and Pfizer Inc. (PFE). ------------------------------------------------------------- Infrastructure Stocks To Consider - July 12th This second article features a sector favoured by many ethical and sustainable investors. The article is titled Infrastructure Stocks To Consider - July 12th. It's by MarketBeat and seen on marketbeat.com. Here are some quotes from the article. “1. NVIDIA Corporation (NASDAQ:NVDA) provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. 2. Coinbase Global, Inc. (NASDAQ:COIN) provides financial infrastructure and technology for the crypto economy in the United States and internationally. The company offers the primary financial account in the crypto economy for consumers; and a marketplace with a pool of liquidity for transacting in crypto assets for institutions. Read Our Latest Research Report on COIN 3. Alphabet (NASDAQ:GOOGL) offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube. Read Our Latest Research Report on GOOGL 4. Broadcom (NASDAQ:AVGO) designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. Read Our Latest Research Report on AVGO 5. Oracle (ORCL) offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.” End quotes. ------------------------------------------------------------- Best Lithium Mining Stocks 2025: Buy Top Mining Stocks Now Every investor knows that lithium is a basic mineral for electric batteries. So, this next article will interest many investors. It's titled Best Lithium Mining Stocks 2025: Buy Top Mining Stocks Now. It's by Farmonaut and found on farmonaut.com. Here are some quotes by Farmonaut on each of their picks. “1. Albemarle Corporation (NYSE: ALB) headquartered in the USA, is the world's largest lithium producer… With operations spanning North America, South America, and Australia, Albemarle boasts: Diversified extraction & processing operations, including high-margin lithium brine and hard rock mining projects Ongoing investments to expand production capacity in Nevada (USA), Chile, and Australia A resilient supply chain and ability to scale output to meet global demand Strategic partnerships with leading EV battery makers Strong commitment to sustainable mining and ESG practices Albemarle's scale, geographic diversification, and innovation position it as one of the best performing mining stocks of 2025. 2. Sociedad Química y Minera de Chile (or SQM) (NYSE: SQM) is South America's lithium market leader. Based in Santiago, Chile, SQM boasts some of the world's largest and lowest-cost lithium brine operations situated in the renowned Lithium Triangle (Chile, Argentina, Bolivia): Extensive lithium reserves & robust extraction technology, delivering high efficiency Geopolitical stability—Chile enjoys a relatively favorable mining regulatory environment compared to other regions Cost-effective production enables SQM to remain highly profitable even as competition heats up Continuous expansion to satisfy increasing global lithium demand for EV batteries and storage solutions Environmental sustainability programs, making SQM attractive for ESG-focused investors SQM competitive positioning ensures it remains a top choice in the best lithium mining stocks to buy for 2025. 3. Livent Corporation (NYSE: LTHM) distinguishes itself by focusing on high-purity lithium chemicals for next-generation battery technologies. With operations in the United States, Argentina, and China, Livent stands out for: Supplying premium lithium hydroxide and carbonate solutions for advanced battery manufacturers Strong partnerships with key players in the EV battery chain, including Tesla Expansion projects in Argentina and the U.S., boosting 2025 production capacity and flexibility ESG and sustainability initiatives for responsible lithium extraction Livent is uniquely positioned for specialty market growth, making it one of the best lithium mining stocks for investors eyeing niche applications and supply chain integration. 4. Piedmont Lithium (NASDAQ: PLL) though a smaller player, it has become a rising star by focusing on high-quality spodumene reserves in the United States—especially in North Carolina's Carolina Tin-Spodumene Belt. Piedmont brings: Strategic U.S. supply source—critical for domestic battery manufacturers and government-led supply chain diversification Fast-tracked expansion projects supported by U.S. regulatory incentives and EV adoption targets Potential to benefit from blockchain-based traceability in mining—enhancing transparency for institutional investors Growing interest from global automakers and battery companies seeking secure lithium supply Piedmont's agility and domestic positioning could mean outsized growth as U.S. policy emphasizes onshoring critical battery mineral chains.” End quotes. ------------------------------------------------------------- 5 Artificial Intelligence (AI) Infrastructure Stocks Powering the Next Wave of Innovations Now, like most investors, you probably are invested in AI stocks, either directly or via funds. Hence, this next article 5 Artificial Intelligence (AI) Infrastructure Stocks Powering the Next Wave of Innovations, should interest you. It's by Justin Pope and found on fool.com. Here is some of what Mr. Pope says about his picks. “1. Nvidia (NASDAQ: NVDA) The company has maintained its winning position as it progressed from its previous Hopper architecture to its current Blackwell chips, and it expects to launch its next-generation architecture, with a CPU called Vera and a GPU called Rubin, next year. Analysts expect Nvidia's revenue to grow to $200 billion this year and $251 billion in 2026.  2. Amazon (AMZN) Web Services (AWS) has long been the world's leading cloud platform, with about 30% of the cloud infrastructure market today. Through the cloud, companies can access and deploy AI agents, models, and other software throughout their businesses. 3. Microsoft (MSFT) Its Azure is the world's second-largest cloud platform, with a market share of approximately 21%. Microsoft stands out from the pack for its deep ties with millions of corporate clients. 4. Arista Networks (ANET) sells high-end networking switches and software that help accomplish this. The company has already thrived in this golden age of data centers, with top clients including Microsoft and Meta Platforms, which happen to also be among the highest spenders on AI infrastructure. 5. Broadcom (AVGO) which specializes in designing semiconductors used for networking applications. For example, Arista Networks utilizes Broadcom's Tomahawk and Jericho silicon in the networking switches it builds for data centers. Broadcom's AI-related semiconductor sales increased by 46% year-over-year in the second quarter.” End quotes. ------------------------------------------------------------- Ethical Companies To Invest In 2025 (ECL, MSFT, UNFI) The final reviewed article for this podcast episode is titled Ethical Companies To Invest In 2025 (ECL, MSFT, UNFI) and was written by the Analyst Team and seen on asktraders.com. Now a few quotes from the article by the Team. “1. Ecolab (ECL) a global leader in water, hygiene, and infection prevention solutions, presents a straightforward ethical narrative. Its products and services help businesses reduce water consumption, improve hygiene standards, and prevent infections, contributing directly to public health and environmental protection… Analyst ratings remain in line with current pricing, with Wells Fargo & Company reiterating a price target of $260.00 in May 2025. With the Ecolab stock price having gained 14% since the start of the year, the company has managed to outperform the market on the period whilst holding true to it's ethical standing. While its dividend yield of approximately 1.1% is slightly higher than others on the list, its P/E ratio of around 38x indicates a similar valuation based on future earnings potential. 2. Microsoft (MSFT) presents a complex ethical profile. On one hand, its commitment to carbon neutrality, investments in renewable energy, and initiatives to bridge the digital divide are commendable… The stock's impressive 20% YTD return and a consensus analyst price target of $475 reflect market confidence in its financial stability and future growth, primarily driven by its cloud and AI segments, making it one to keep on shortlists… While Microsoft offers a modest dividend yield of around 0.7%, its high P/E ratio of approximately 36x suggests a premium valuation reflecting its growth potential rather than a focus on immediate shareholder returns. The company's low debt-to-equity ratio underscores its financial strength, allowing it to invest heavily in research and development and pursue ambitious sustainability goals. 3. United Natural Foods (UNFI) stock has pulled back ~15% this year, although remains firmly higher over the past 12 months, with a gain of more than 70%. The company, a leading distributor of natural, organic, and specialty foods, presents the most challenging investment case with the recent cyber incident causing a sharp pullback in the stock. This could in fact be an opportunity… Unlike Microsoft and Ecolab, United Natural Foods does not offer a dividend, reflecting its current financial constraints. Its low P/E ratio of around 8x suggests a deeply discounted valuation, reflecting the market's skepticism about its turnaround prospects. Recent earnings on July 16 beat expectations, however, and the stock is on the move with an 8% gain immediately off the back.” End quotes. ------------------------------------------------------------- More articles of interest from around the world for ethical and sustainable investors 1. Title: Top 10: Wind Power Companies on energydigital.com. By Jasmin Jessen. 2. Title: Ethical Companies To Invest In 2025 (ECL, MSFT, UNFI) on AskTraders.com. By Analyst Team. 3. Title: The Green Gold Rush: Why Techem's $6.7B Sale Signals a Buying Opportunity on ainvest.com. By Wesley Park. 4. Title: AJ Bell adds Rathbone Ethical Bond to buy list on portfolio-advisor.com. By Christian Mayes. 5. Title: Procter & Gamble Named Top Socially Responsible Dividend Stock on ainvest.com. By Ainvest. 6. Title: 11 Best Halal Dividend Stocks to Buy Now on insidermonkey.com. By Vardah Gill. 7. Title: JPMorgan Picks 3 Top Stocks In Alternative Energy On Heels Of Trump's 'Big Beautiful Bill' - First Solar (NASDAQ:FSLR), Brookfield Renewable (NYSE:BEPC), and HASI (NYSE:HASI) on benzinga.com. By Priya Nigam. ------------------------------------------------------------- Ending Comment These are my top news stories with their stock and fund tips for this podcast, “12 Articles With Great ESG Stock Picks.” Please click the like and subscribe buttons wherever you download or listen to this podcast. That helps bring these podcasts to others like you. And please click the share buttons to share this podcast with your friends and family. Let's promote ethical and sustainable investing as a force for hope and prosperity in these deeply troubled times! Contact me if you have any questions. Thank you for listening. As I mentioned earlier, I'm taking some time off, so I'll talk to you next on August 22nd. Bye for now.   © 2025 Ron Robins, Investing for the Soul

Notas del Show: En este episodio cubrimos los eventos más relevantes antes de la apertura del mercado: • Wall Street opera mixto ante expectativa inflacionaria: Futuros sin dirección clara: $SPX plano, $US100 -0.1%, $INDU +0.1%. El mercado asimila el IPC de junio mientras se publican el IPP (0.2% m/m esperado) y resultados de $BAC, $GS y $MS. Las tasas a 10 y 2 años se mantienen estables. • Trump lanza mega plan de energía e IA desde Pennsylvania: Se anunciaron inversiones por $36B en centros de datos y $56B en energía. Hiperescaladores como $AMZN, $GOOG y $CRWV participarán. Wedbush estima un gasto de $2T en IA en los próximos tres años. • Critical Metals se dispara por avances en Groenlandia: $CRML +32.7% tras lanzar programa de perforación en Tanbreez. El yacimiento suma 22.56B toneladas y podría valer hasta $3.6B. El estudio de viabilidad y expansión del depósito Fjord generan gran expectativa. • Trump evalúa aranceles a fármacos y chips a fin de mes: Nuevas tarifas afectarían a $PFE, $MRK, $LLY, $AAPL y $SSNLF. Iniciaría con tasas bajas y subiría hasta 200%. Se esperan acuerdos bilaterales antes del 1 de agosto, con India como prioridad. Una jornada de inflación, resultados bancarios y posicionamientos estratégicos de Trump en IA, energía y comercio global. ¡No te lo pierdas!

Dagli studi radiofonici del Parlamento europeo di Strasburgo, la nostra intervista all'eurodeputato Roberto Vannacci (PfE). Una lunga chiacchierata su alcuni dei temi più attuali dell’agenda europea: dai conflitti in Ucraina e in Medio Oriente, fino alla discussione sulla difesa comune europea. Se avete già visto il nostro reel con Vannacci, non potete perdetevi l'intervista integrale! Il contenuto è stato […]

En este episodio cubrimos los eventos más relevantes antes de la apertura del mercado: • Wall Street se estabiliza tras repunte reciente: Los futuros moderan: $SPX -0.3%, $US100 -0.4%, $INDU -0.2%. Los bonos del Tesoro también retroceden. El mercado consolida tras varios días de ganancias impulsadas por la tregua comercial EE.UU.–China y datos de inflación a la baja. Hoy no hay reportes económicos clave, pero hablarán varios miembros de la Fed, en medio de señales de cautela sobre política monetaria. • Waymo extiende su red de robotaxis: $GOOG $GOOGL recibió aprobación para expandir Waymo One en el Área de la Bahía, incluyendo San José. Junto a $UBER, inició operaciones piloto en Atlanta con lanzamiento completo previsto para verano. Waymo ya realiza 250,000 viajes pagos semanales en 4 ciudades y proyecta llegar a Miami y Washington D.C. en 2026. • Pfizer amplía su cartera oncológica con biotech china: $PFE firmó un acuerdo global con 3SBio por el desarrollo del anticuerpo SSGJ-707, con pagos potenciales de hasta $6 Billones. El tratamiento, actualmente en fase clínica en China, será producido en EE.UU. y entrará en fase 3 en 2025. Pfizer también invertirá $100M en acciones de 3SBio, consolidando su presencia en el mercado asiático. • Delta demanda a CrowdStrike por fallo global: $DAL avanza con una demanda contra $CRWD tras el colapso del software de ciberseguridad en julio de 2024. La aerolínea reclama $500 Billones en pérdidas por interrupciones operativas y cancelaciones. Un tribunal de Georgia permitió continuar con cargos por negligencia grave. Paralelamente, $DAL enfrenta una demanda colectiva de pasajeros. Una jornada de calma en los mercados, mientras destacan avances tecnológicos, apuestas farmacéuticas y batallas legales de alto impacto. ¡No te lo pierdas!

En este episodio analizamos las claves del inicio de semana en los mercados: • Wall Street vuela tras tregua EE.UU.–China: Futuros al alza con $SPX +3.1%, $US100 +4% y $INDU +2.4%. EE.UU. y China acordaron reducir aranceles por 90 días: Washington bajará del 145% al 30% y Pekín del 125% al 10%. Las conversaciones en Suiza fueron calificadas como “productivas” y se creará un mecanismo de consultas para seguir negociando. El mercado también espera el CPI de abril mañana. • Acuerdo alivia guerra arancelaria: El pacto cubre la mayoría de tarifas recíprocas recientes. Ambas potencias mantendrán la pausa mientras discuten nuevos términos. Se evalúa una posible reunión en EE.UU., China o un país neutral. Las bolsas globales reaccionan con fuerza al anuncio. • Trump golpea a farmacéuticas con nueva orden: El presidente anunció una orden ejecutiva para reducir precios de medicamentos entre 30%-80%, alineándolos con estándares internacionales. $LLY -2.2%, $AMGN -2.6%, $MRK -2.4%, $PFE -3.3%. En Europa, $AZN -5% y $GSK -2.6%. El sector salud fue el más afectado en Asia. Un episodio donde la diplomacia comercial domina el panorama, pero también se encienden alarmas en el sector farmacéutico global.

Tracey Ryniec, Zacks Senior Stock Strategist, and Bryan Hayes, editor of Zacks Income Investor newsletter, discuss 5 popular stocks with high dividend yields. Can the dividend be trusted?   (1:00) - Should You Be Investing Into High Paying Income Stocks? (8:40) - Top Stocks To Keep On Your Watchlist Right Now (36:45) - Episode Roundup: WHR, PFE, CVX, CC, DOW

En este episodio, repasamos los temas más importantes del día: • Wall Street celebra resultados tech: Los futuros suben con fuerza tras sólidos earnings de $MSFT (+8.2% premarket) y $META (+6.2%). $SPX +1.2%, $US100 +1.6% y $INDU +0.7%. Wall Street cerró con rebote tras la primera contracción del PIB desde 2022. Hoy se esperan datos de desempleo (224K), PMI e ISM de abril. • Trump impulsa vacuna universal: La administración lanza el programa “Generation Gold Standard” con $500B para desarrollar vacunas contra múltiples virus. Se usarán tecnologías clásicas como virus inactivados. Ensayos planeados para 2026; aprobación esperada en 2029. Involucra a $AZN, $GSK, $SNY, $PFE, $MRNA, $NVAX y otras. • Amazon amplía cobertura rural: $AMZN invertirá $4B en expandir su red de entregas en zonas rurales, cubriendo 13,000 códigos postales y creando 100,000 empleos. La iniciativa permitirá más de mil millones de paquetes adicionales al año. Acciones suben +2.7% tras el anuncio. Un episodio que destaca innovación médica, expansión logística y el poder de las tecnológicas en el mercado. ¡Dale play y no te lo pierdas!

S&P Futures are giving up early morning gains and are now trading lower. Key news stories this morning is the pending announcement from the Trump Administration that they will be lowering some tariffs on auto parts. Earnings remain a key focus for today. PFE, HON, HLT & UPS are trading higher after their earnings releases. After the bell today, V, SBUX, MDLZ & PPG are scheduled to report. The next three days feature a flood of first-quarter earnings from large U.S. and international companies. On the economic calendar for today is the latest Consumer Confidence reading and the JOLTs report.

S&P Futures are weakening this morning as the market heads into a key trading week. Treasury Secretary Scott Bessent defended the Trump administrations tariff plan over the weekend and said that he expects a "de-escalation" with China in the short term, followed by an agreement in principle before an actual trade deal is worked out in the coming months. He is schedule to give an interview this morning at 8:00 am with CNBC. Fed officials have entered into a blackout period ahead of the upcoming Fed Meeting next week. The week ahead has a host of key economic reports due out including GDP, PCE, & Non-Farm Payrolls. Earnings Seasons is here with reports due out this week from HON, PFE, KO, V, SBUX, MSFT, META QCOM, AMGN, AAPL & AMZN.

S&P Futures are weakening this morning after multiple days of strong gains. Earnings and Trade Talks are the key themes for the day. Google released a strong earnings report yesterday; their operating income was a key highlight. Both the U.S. and China appear to be ready to start to de-escalate the trade tensions which is a key step that needs to happen in order for talks to begin. The U.S. will be announcing trade deals with South Korea, India and possibly Japan. The deals will be more political theater than a true agreement. On the economic front today is the final consumer sentiment reading for April from the Universite of Michigan. Earnings Seasons picks up next week with reports due out from HON, PFE, KO, V, SBUX, MSFT, META QCOM, AMGN, AAPL & AMZN. Q1 tech earnings have been coming in better than expected.

Eric Beyrich says, “this is the time of year we actually thrive” as he looks at a low-bid, high-yield strategy. He compares the ratio of value to growth in the market and says there's a “long way to go” to get back to equilibrium after tech's massive run. He expects the S&P 500 to have a bad year, but most stocks to have an up year. His picks include ADT, DOW, PFE, AMCR, and BERY.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Karen Anderson, director of healthcare equity research for Morningstar Research Services, discusses the forces shaping the landscape and where she sees opportunities for investors.  Key Takeaways:Why Healthcare Stocks Have Been Resilient During the Market DownturnHow Regulatory Changes Could Affect the Healthcare IndustryWhy Healthcare Stocks' Valuations Look Attractive From a Bottom-Up ViewHow Have Healthcare Stocks' Valuations Changed Historically?How Stock Valuations Differ Within the Healthcare Sector  How an Aging US Population Affects the Healthcare Sector  Will GLP-1 Drugs Continue to Grow?  Regulatory Risks for Healthcare Stocks  Healthcare Stocks Outlook  Are Healthcare Stocks a Buy?  Healthcare Stock Picks  How Amgen Is Using AI in Healthcare   Read about topics from this episode.  Healthcare: Sector Looks Undervalued with Pullback After US Election and Obesity DataNovo Nordisk: Next-Generation GLP-1/Amylin Drug Sees Leading Weight Loss in Small TrialHow GLP-1 Drugs Like Ozempic Are Boosting Biopharma StocksBiopharma Stock Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges22 Best Healthcare Companies to Invest In  What to watch from Morningstar.Worried About a Market Sell-Off? These 10 Funds Reduce Portfolio Risk Gray Divorce: How to Avoid Triggering a Costly Tax BillWhy the Bond Market Looks Brighter Than It Did in 2022Where to Find Bargain Stocks in an Expensive Market  Read what our team is writing:Karen AndersenSarah Hansen Follow us on social media.Facebook: https://www.facebook.com/MorningstarInc/X: https://x.com/MorningstarIncInstagram: https://www.instagram.com/morningstar... LinkedIn: https://www.linkedin.com/company/5161/ 

S&P Futures are weakening this morning as the markets is now focused on the pending Trump Tariff announcement which is scheduled for April 2nd. Travel stocks are moving lower this morning as London's Heathrow airport has been closed due to a fire at a nearby electrical substation. President Trump & Defense Secretary are scheduled to speak at 11:00 am this morning. On Sunday, the China Development Forum begins, CEO's from QCOM, FDX, MA, AVGO, PFE are expected to attend. FDX, NKE & LEN are lower after earnings announcements. Macro uncertainties in the world is likely to be a key theme when earnings season kicks off next month.

$150 billion. That's how much some experts estimate weight-loss drugs could bring in in sales within the next five years. Motley Fool analyst Karl Thiel joins Ricky Mulvey to check in on the GLP-1 landscape. They also discuss: - How weight-loss drugs actually work, and how big-name prescriptions differ from each other. - What investors need to know about Ozempic and Mounjarno's patent cliffs. - The scenarios in which Novo Nordisk and Eli Lilly are actually undervalued. Companies discussed: LLY, NOVO, HIMS, PFE, RHHBY, VKTX, GPCR, ISRG Host: Ricky Mulvey Guest: Karl Thiel Producer: Mary Long Engineer: Rick Engdahl Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we explore where value might be hiding in today's high-valuation market. From overlooked oil and gas plays to global opportunities in Japanese railways and Chinese big tech, we break down areas of potential interest for savvy investors. We also discuss the pitfalls and potential in pharma, defense, and precious metal miners, as well as the challenges pandemic darlings face in a post-COVID world. Plus, Braden dives into the concept of quality in investing, inspired by Dev Kantesaria of Valley Forge Capital. Discover why the intersection of growth and predictability defines great companies and how this framework can help you identify enduring opportunities in any market environment. Tickers of Stocks/ETFs discussed: HAL, TVK.TO, CNQ.TO, TOU.TO, ENB.TO, TRP.TO, KMI, MPC, JNJ, PFE, MRK, LLY, NVO, KVUE,PPH, IHE, ZHU.TO, LMT, UNP, 9020, KWEB, BABA, FNV.TO, WPM.TO, ABX.TO, NGT.TO, GDX, GDXJ, ZGD.TO, DOO.TO, 7309 Check out our portfolio by going to Jointci.com Our Website Canadian Investor Podcast Network Twitter: @cdn_investing Simon’s twitter: @Fiat_Iceberg Braden’s twitter: @BradoCapital Dan’s Twitter: @stocktrades_ca Want to learn more about Real Estate Investing? Check out the Canadian Real Estate Investor Podcast! Apple Podcast - The Canadian Real Estate Investor Spotify - The Canadian Real Estate Investor Web player - The Canadian Real Estate Investor Asset Allocation ETFs | BMO Global Asset Management Sign up for Finchat.io for free to get easy access to global stock coverage and powerful AI investing tools. Register for EQ Bank, the seamless digital banking experience with better rates and no nonsense.See omnystudio.com/listener for privacy information.

Peace out 2024... Let's get set for 2025! What stocks and situations do we see working for 2025? We break down the market and look into stocks that could soar into the new year. Some of our favorite picks for 2024 could still be winners while others are at the point of being overvalued in the short term. I'm looking at LLY Eli Lilly, AMZN Amazon, AMD Advanced Micro Devices , ADBE Adobe, LMT Lockheed Martin as well as many other AI software, AI Hardware, tech and defense plays. We also check on some other ETFs that can fit our needs while diversifying away from single stock exposure. WEEK 1 SELL $PLUG, $HNST, $SHOP. BUY $DVN, $MPW, $NEE, WEEK 2 $NVDA, WEEK 3 $HASI, WEEK 4 $CRSP, WEEK 5 $TSM, WEEK 6 $MSFT, WEEK 7 $XOM, WEEK 8 $BMY, WEEK 9 $O, WEEK 10 $KO, WEEK 11 $SOUN, WEEK 12 $IRM and $AAPL WEEK 13 $AMD, WEEK 14 $CVX, WEEK 15 $AMZN, WEEK 16 $INTC/$X, WEEK 17 $V, WEEK 18 $O, WEEK 19 $META, WEEK 20 $CIVI, WEEK 21 $BRCC, WEEK 22 $WBA, WEEK 23 $COST, WEEK 24 $CVX, WEEK 25 $MO, WEEK 26 $AMZN, WEEK 27$UPS, WEEK 28 $JNJ, WEEK 29 $V, WEEK 30 $SOFI, WEEK 31 $XOM, WEEK 32 $NEE, WEEK 33 $MPW, WEEK 34 $PLTR, WEEK 35 $IBIT, WEEK 36 $DVN, WEEK 37 $S, WEEK 38 $UPS, WEEK 39 $CVX, WEEK 40 $C, WEEK $41 COST, WEEK 42 $DVN, WEEK 43 $PFE, WEEK 44 $CELH, WEEK 45 $C, WEEK 46 $UPS, WEEK 47 $CIVI, WEEK 48 $LLY, WEEK 49 $CELH, WEEK 50 $AMD, WEEK 51 $AMZN, WEEK 52 $AMD As always, I thank each and every one of you for listening in, voting, and following along to the podcast and group! It has been a fun journey gathering info and sharing it with you all every week. Please make sure to subscribe, share and should you have questions, please feel free to ask and I'll do my best to cover them.  ***Not investing advice, simply what I am looking to do in my own portfolio while understanding my risks, timeline, age, income, debt and other factors!!*** As always, thank you for continuing to support the page and podcast, by liking, subscribing and sharing!  www.1stphorm.com/letitgrow https://barbellapparel.com/?rstr=Letitgrowbarbellapparel FB GROUP:  https://www.facebook.com/groups/3149013668660459/  E-Trade Referral code https://refer.etrade.net/jsebastian1987  https://accounts.binance.us/en/register?ref=53539239  Use my referral link https://crypto.com/app/3jsnadjrsq to sign up for Crypto.com and we both get $25 USD.  Open an account on webull, make a deposit and get a free share valued between $8-$2000!! https://a.webull.com/iq6NLY31wXgKyPlM1g  If anyone is reading down here, you are the real MVP!! Thanks for your support and making our community a better place and for making me a better investor. I hope you've learned something; I certainly have! Let's get out there and "LET IT GROW" --- Support this podcast: https://podcasters.spotify.com/pod/show/letitgrow/support

Covering all the action from the Fed with a 25 bps cut to the Fed funds rate. Action from Merck licensing a GLP-1 drug from LaNova Medicines and the ripple effect it caused in the other pharma stocks. AMD vs. NVDA for 25! Still going long on AMD but not ignoring that NVDA is in correction territory and has increasing revenue for the foreseeable future. We purchased AMD for week #52 of our investing challenge. Micron MU reported decent earnings and guided light for the first half of 25 which sent the stock price plummeting. WEEK 1 SELL $PLUG, $HNST, $SHOP. BUY $DVN, $MPW, $NEE, WEEK 2 $NVDA, WEEK 3 $HASI, WEEK 4 $CRSP, WEEK 5 $TSM, WEEK 6 $MSFT, WEEK 7 $XOM, WEEK 8 $BMY, WEEK 9 $O, WEEK 10 $KO, WEEK 11 $SOUN, WEEK 12 $IRM and $AAPL WEEK 13 $AMD, WEEK 14 $CVX, WEEK 15 $AMZN, WEEK 16 $INTC/$X, WEEK 17 $V, WEEK 18 $O, WEEK 19 $META, WEEK 20 $CIVI, WEEK 21 $BRCC, WEEK 22 $WBA, WEEK 23 $COST, WEEK 24 $CVX, WEEK 25 $MO, WEEK 26 $AMZN, WEEK 27$UPS, WEEK 28 $JNJ, WEEK 29 $V, WEEK 30 $SOFI, WEEK 31 $XOM, WEEK 32 $NEE, WEEK 33 $MPW, WEEK 34 $PLTR, WEEK 35 $IBIT, WEEK 36 $DVN, WEEK 37 $S, WEEK 38 $UPS, WEEK 39 $CVX, WEEK 40 $C, WEEK $41 COST, WEEK 42 $DVN, WEEK 43 $PFE, WEEK 44 $CELH, WEEK 45 $C, WEEK 46 $UPS, WEEK 47 $CIVI, WEEK 48 $LLY, WEEK 49 $CELH, WEEK 50 $AMD, WEEK 51 $AMZN, WEEK 52 $AMD As always, I thank each and every one of you for listening in, voting, and following along to the podcast and group! It has been a fun journey gathering info and sharing it with you all every week. Please make sure to subscribe, share and should you have questions, please feel free to ask and I'll do my best to cover them.  ***Not investing advice, simply what I am looking to do in my own portfolio while understanding my risks, timeline, age, income, debt and other factors!!*** As always, thank you for continuing to support the page and podcast, by liking, subscribing and sharing!  www.1stphorm.com/letitgrow https://barbellapparel.com/?rstr=Letitgrowbarbellapparel FB GROUP:  https://www.facebook.com/groups/3149013668660459/  E-Trade Referral code https://refer.etrade.net/jsebastian1987  https://accounts.binance.us/en/register?ref=53539239  Use my referral link https://crypto.com/app/3jsnadjrsq to sign up for Crypto.com and we both get $25 USD.  Open an account on webull, make a deposit and get a free share valued between $8-$2000!! https://a.webull.com/iq6NLY31wXgKyPlM1g  If anyone is reading down here, you are the real MVP!! Thanks for your support and making our community a better place and for making me a better investor. I hope you've learned something; I certainly have! Let's get out there and "LET IT GROW" --- Support this podcast: https://podcasters.spotify.com/pod/show/letitgrow/support

Tom Vice is the CEO of Sierra Space, a company building an end-to-end business and technology platform in space to benefit life on earth. Think, space planes and inflatable space habitats. Ricky Mulvey caught up with Vice at the Sierra Space headquarters for a show that originally aired on March 30, 2024. They discuss: - The magic of microgravity, and its impact on everything from biotech and batteries to chemistry and computing. - How rent works in outer space. - Defense systems and the hope of a space-based “McDonald's Effect.” Companies mentioned: MRK, PFE, MRNA, NVDA Host: Ricky Mulvey Guest: Tom Vice Producer: Mary Long Engineers: Desireé Jones, Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

We take a deeper dive into why AMD could be a great addition to my portfolio for the next few years! We estimate out the growth and stock price into 2028 and look at some of the financials behind the company and why there might be a narrow window before this one starts to take off! Also, we dive into some other stocks that could give us some outsized gains for the new year! Eli Lilly has been cut down, but they have announced a huge share buyback and just raised their dividend. UNH has had their share price knocked down after their CEO was murdered in NYC. What stock are you picking to finish out the year? WEEK 52 Investing challenge! 1. ADBE Adobe 2. LLY Eli Lilly 3. MDB MongoDB 4. UNH United Healthcare 5. AMD Advanced Micro Devices WEEK 1 SELL $PLUG, $HNST, $SHOP. BUY $DVN, $MPW, $NEE, WEEK 2 $NVDA, WEEK 3 $HASI, WEEK 4 $CRSP, WEEK 5 $TSM, WEEK 6 $MSFT, WEEK 7 $XOM, WEEK 8 $BMY, WEEK 9 $O, WEEK 10 $KO, WEEK 11 $SOUN, WEEK 12 $IRM and $AAPL WEEK 13 $AMD, WEEK 14 $CVX, WEEK 15 $AMZN, WEEK 16 $INTC/$X, WEEK 17 $V, WEEK 18 $O, WEEK 19 $META, WEEK 20 $CIVI, WEEK 21 $BRCC, WEEK 22 $WBA, WEEK 23 $COST, WEEK 24 $CVX, WEEK 25 $MO, WEEK 26 $AMZN, WEEK 27$UPS, WEEK 28 $JNJ, WEEK 29 $V, WEEK 30 $SOFI, WEEK 31 $XOM, WEEK 32 $NEE, WEEK 33 $MPW, WEEK 34 $PLTR, WEEK 35 $IBIT, WEEK 36 $DVN, WEEK 37 $S, WEEK 38 $UPS, WEEK 39 $CVX, WEEK 40 $C, WEEK $41 COST, WEEK 42 $DVN, WEEK 43 $PFE, WEEK 44 $CELH, WEEK 45 $C, WEEK 46 $UPS, WEEK 47 $CIVI, WEEK 48 $LLY, WEEK 49 $CELH, WEEK 50 $AMD, WEEK 51 $AMZN, WEEK 52 $AMD As always, I thank each and every one of you for listening in, voting, and following along to the podcast and group! It has been a fun journey gathering info and sharing it with you all every week. Please make sure to subscribe, share and should you have questions, please feel free to ask and I'll do my best to cover them.  ***Not investing advice, simply what I am looking to do in my own portfolio while understanding my risks, timeline, age, income, debt and other factors!!*** As always, thank you for continuing to support the page and podcast, by liking, subscribing and sharing!  www.1stphorm.com/letitgrow https://barbellapparel.com/?rstr=Letitgrowbarbellapparel FB GROUP:  https://www.facebook.com/groups/3149013668660459/  E-Trade Referral code https://refer.etrade.net/jsebastian1987  https://accounts.binance.us/en/register?ref=53539239  Use my referral link https://crypto.com/app/3jsnadjrsq to sign up for Crypto.com and we both get $25 USD.  Open an account on webull, make a deposit and get a free share valued between $8-$2000!! https://a.webull.com/iq6NLY31wXgKyPlM1g  If anyone is reading down here, you are the real MVP!! Thanks for your support and making our community a better place and for making me a better investor. I hope you've learned something; I certainly have! Let's get out there and "LET IT GROW" --- Support this podcast: https://podcasters.spotify.com/pod/show/letitgrow/support

Which stocks do you have that you plan to keep forever? I have a few that I have trimmed or pulled some profits from but don't plan to sell out of anytime soon! They might not be the best entry point at the moment but if we look long term and want to build a position in these names we can dollar cost average our way into a full position. I've made a tough decision to make this episode showing my own personal holdings in hopes that it helps someone else see that it is possible to set yourself up financially without crazy risk, options, gambling, or betting on one single play. Yes, those plays have made some people rich but also ended up breaking the majority of investors. Buying $AMD for week 50! Week 51 stock of the week, buy and hold forever picks! 1. AMZN 2. META 3. TSLA 4. HD 5. JPM WEEK 1 SELL $PLUG, $HNST, $SHOP. BUY $DVN, $MPW, $NEE, WEEK 2 $NVDA, WEEK 3 $HASI, WEEK 4 $CRSP, WEEK 5 $TSM, WEEK 6 $MSFT, WEEK 7 $XOM, WEEK 8 $BMY, WEEK 9 $O, WEEK 10 $KO, WEEK 11 $SOUN, WEEK 12 $IRM and $AAPL WEEK 13 $AMD, WEEK 14 $CVX, WEEK 15 $AMZN, WEEK 16 $INTC/$X, WEEK 17 $V, WEEK 18 $O, WEEK 19 $META, WEEK 20 $CIVI, WEEK 21 $BRCC, WEEK 22 $WBA, WEEK 23 $COST, WEEK 24 $CVX, WEEK 25 $MO, WEEK 26 $AMZN, WEEK 27$UPS, WEEK 28 $JNJ, WEEK 29 $V, WEEK 30 $SOFI, WEEK 31 $XOM, WEEK 32 $NEE, WEEK 33 $MPW, WEEK 34 $PLTR, WEEK 35 $IBIT, WEEK 36 $DVN, WEEK 37 $S, WEEK 38 $UPS, WEEK 39 $CVX, WEEK 40 $C, WEEK $41 COST, WEEK 42 $DVN, WEEK 43 $PFE, WEEK 44 $CELH, WEEK 45 $C, WEEK 46 $UPS, WEEK 47 $CIVI, WEEK 48 $LLY, WEEK 49 $CELH, WEEK 50 $AMD As always, I thank each and every one of you for listening in, voting, and following along to the podcast and group! It has been a fun journey gathering info and sharing it with you all every week. Please make sure to subscribe, share and should you have questions, please feel free to ask and I'll do my best to cover them.  ***Not investing advice, simply what I am looking to do in my own portfolio while understanding my risks, timeline, age, income, debt and other factors!!*** As always, thank you for continuing to support the page and podcast, by liking, subscribing and sharing!  www.1stphorm.com/letitgrow https://barbellapparel.com/?rstr=Letitgrowbarbellapparel FB GROUP:  https://www.facebook.com/groups/3149013668660459/  E-Trade Referral code https://refer.etrade.net/jsebastian1987  https://accounts.binance.us/en/register?ref=53539239  Use my referral link https://crypto.com/app/3jsnadjrsq to sign up for Crypto.com and we both get $25 USD.  Open an account on webull, make a deposit and get a free share valued between $8-$2000!! https://a.webull.com/iq6NLY31wXgKyPlM1g  If anyone is reading down here, you are the real MVP!! Thanks for your support and making our community a better place and for making me a better investor. I hope you've learned something; I certainly have! Let's get out there and "LET IT GROW" --- Support this podcast: https://podcasters.spotify.com/pod/show/letitgrow/support

In this episode we look at the last companies to report earnings. Which stocks still have room left to run for the remainder of the year and beyond? After much of the market has already moved as some of the uncertainty settles down, is there anything left to buy at a reasonable valuation? I think we have found a few that deserve a closer look! Sold TSLA covered calls at $300 Closed NVDA calls @ $170 UMAC and ACHR rally higher on drone talks-- WEEK 50 1. AMD 2. DELL 3. GOOGL 4. LHX 5. LMT WEEK 1 SELL $PLUG, $HNST, $SHOP. BUY $DVN, $MPW, $NEE, WEEK 2 $NVDA, WEEK 3 $HASI, WEEK 4 $CRSP, WEEK 5 $TSM, WEEK 6 $MSFT, WEEK 7 $XOM, WEEK 8 $BMY, WEEK 9 $O, WEEK 10 $KO, WEEK 11 $SOUN, WEEK 12 $IRM and $AAPL WEEK 13 $AMD, WEEK 14 $CVX, WEEK 15 $AMZN, WEEK 16 $INTC/$X, WEEK 17 $V, WEEK 18 $O, WEEK 19 $META, WEEK 20 $CIVI, WEEK 21 $BRCC, WEEK 22 $WBA, WEEK 23 $COST, WEEK 24 $CVX, WEEK 25 $MO, WEEK 26 $AMZN, WEEK 27$UPS, WEEK 28 $JNJ, WEEK 29 $V, WEEK 30 $SOFI, WEEK 31 $XOM, WEEK 32 $NEE, WEEK 33 $MPW, WEEK 34 $PLTR, WEEK 35 $IBIT, WEEK 36 $DVN, WEEK 37 $S, WEEK 38 $UPS, WEEK 39 $CVX, WEEK 40 $C, WEEK $41 COST, WEEK 42 $DVN, WEEK 43 $PFE, WEEK 44 $CELH, WEEK 45 $C, WEEK 46 $UPS, WEEK 47 $CIVI, WEEK 48 $LLY, WEEK 49 $CELH As always, I thank each and every one of you for listening in, voting, and following along to the podcast and group! It has been a fun journey gathering info and sharing it with you all every week. Please make sure to subscribe, share and should you have questions, please feel free to ask and I'll do my best to cover them.  ***Not investing advice, simply what I am looking to do in my own portfolio while understanding my risks, timeline, age, income, debt and other factors!!*** As always, thank you for continuing to support the page and podcast, by liking, subscribing and sharing!  www.1stphorm.com/letitgrow https://barbellapparel.com/?rstr=Letitgrowbarbellapparel FB GROUP:  https://www.facebook.com/groups/3149013668660459/  E-Trade Referral code https://refer.etrade.net/jsebastian1987  https://accounts.binance.us/en/register?ref=53539239  Use my referral link https://crypto.com/app/3jsnadjrsq to sign up for Crypto.com and we both get $25 USD.  Open an account on webull, make a deposit and get a free share valued between $8-$2000!! https://a.webull.com/iq6NLY31wXgKyPlM1g  If anyone is reading down here, you are the real MVP!! Thanks for your support and making our community a better place and for making me a better investor. I hope you've learned something; I certainly have! Let's get out there and "LET IT GROW" --- Support this podcast: https://podcasters.spotify.com/pod/show/letitgrow/support

Intel, Disney and 3 others have struggled the last 5 years. Should long-time investors double down? (1:00) - Should You Be Buying More Beaten Down Stocks? (6:40) - Top Stocks To Keep On Your Radar Right Now (30:10) - Episode Roundup: WBA, APA, DIS, PFE, INTC

Intel, Disney and 3 others have struggled the last 5 years. Should long-time investors double down? (1:00) - Should You Be Buying More Beaten Down Stocks? (6:40) - Top Stocks To Keep On Your Radar Right Now (30:10) - Episode Roundup: WBA, APA, DIS, PFE, INTC

Andrew Arons with Synergy Advisory Management remains bullish on the state of the markets, crediting A.I. stocks and the Fed's rate cut. He points to a few stocks he believes can pick up steam with the right catalysts. Andrew discusses Paypal (PYPL) as a turnaround play, Pfizer's (PFE) strength in cheap valuation, and how Amazon (AMZN) "will be a winner for a while." ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

S&P Futures are indicating a big move lower this morning. Markets are weakening due to rising bond yields and concerns on geopolitical tensions in the Middle East. CPI data for Sept to be released on Thursday. Apollo is buying the Barnes Group for 47.50 a share. Starboard has taken a position in PFE valued at $1B. Key events this week include TSLA robotaxi announcement, GM's Analysts meeting, and AI events for AMD and HPE. Earnings season gets underway this week. In Europe, markets are mixed this morning. Oil prices are displaying another strong leg higher in the pre-market.

S&P Futures are higher in the pre-market as markets await a host of key earnings reports. MRK, PFE, JBLU & SWK have already reported positive earnings this morning. After the bell today we hear form MSFT, AMD, ANET, SBUX & QRVO. Tomorrow there are two cental Bank announcements, one from the Fed and on from the Bank of Japan. The BOJ and the BOE are also having cental bank meetings this week. Oil prices continue to trend lower on demand concerns and in Europe, markets are mixed to higher as the EuroZone GDP growth rates came in higher than the estimates.

We're back with another episode of The Option Block brought to you by Public.   We break down what's going on in the markets including MCD. We discuss the most active equity options for the day including PLTR, PFE. We talk about earnings volatility this week in MCD, ON, AMD, MSFT, MTCH, SBUX, BA,QCOM, CROX, MRNA, AAPL, AMZN, COIN. We also look at unusual options activity in DBI, GSK, INFA. Uncle Mike Tosaw discusses diversification and we share what we are keeping an eye on for the upcoming week.   With your hosts: Mark Longo, The Options Insider Media Group Andrew "The Rock Lobster" Giovinazzi, The Option Pit "Uncle" Mike Tosaw, St. Charles Wealth Management Options are not suitable for all investors and carry significant risk.  Option investors can rapidly lose the value of their investment in a short period of time and incur permanent loss by expiration date.  Certain complex options strategies carry additional risk.  There are additional costs associated with option strategies that call for multiple purchases and sales of options, such as spreads, straddles, among others, as compared with a single option trade. Prior to buying or selling an option, investors must read and understand the “Characteristics and Risks of Standardized Options”, also known as the options disclosure document (ODD) which can be found at: www.theocc.com/company-information/documents-and-archives/options-disclosure-document Supporting documentation for any claims will be furnished upon request. If you are enrolled in our Options Order Flow Rebate Program, The exact rebate will depend on the specifics of each transaction and will be previewed for you prior to submitting each trade. This rebate will be deducted from your cost to place the trade and will be reflected on your trade confirmation. Order flow rebates are not available for non-options transactions. To learn more, see our Fee Schedule, Order Flow Rebate FAQ, and Order Flow Rebate Program Terms & Conditions. Options can be risky and are not suitable for all investors. See the Characteristics and Risks of Standardized Options to learn more. All investing involves the risk of loss, including loss of principal. Brokerage services for US-listed, registered securities, options and bonds in a self-directed account are offered by Open to the Public Investing, Inc., member FINRA & SIPC. See public.com/#disclosures-main for more information.

We're back with another episode of The Option Block brought to you by Public.   We break down what's going on in the markets including MCD. We discuss the most active equity options for the day including PLTR, PFE. We talk about earnings volatility this week in MCD, ON, AMD, MSFT, MTCH, SBUX, BA,QCOM, CROX, MRNA, AAPL, AMZN, COIN. We also look at unusual options activity in DBI, GSK, INFA. Uncle Mike Tosaw discusses diversification and we share what we are keeping an eye on for the upcoming week.   With your hosts: Mark Longo, The Options Insider Media Group Andrew "The Rock Lobster" Giovinazzi, The Option Pit "Uncle" Mike Tosaw, St. Charles Wealth Management Options are not suitable for all investors and carry significant risk.  Option investors can rapidly lose the value of their investment in a short period of time and incur permanent loss by expiration date.  Certain complex options strategies carry additional risk.  There are additional costs associated with option strategies that call for multiple purchases and sales of options, such as spreads, straddles, among others, as compared with a single option trade. Prior to buying or selling an option, investors must read and understand the “Characteristics and Risks of Standardized Options”, also known as the options disclosure document (ODD) which can be found at: www.theocc.com/company-information/documents-and-archives/options-disclosure-document Supporting documentation for any claims will be furnished upon request. If you are enrolled in our Options Order Flow Rebate Program, The exact rebate will depend on the specifics of each transaction and will be previewed for you prior to submitting each trade. This rebate will be deducted from your cost to place the trade and will be reflected on your trade confirmation. Order flow rebates are not available for non-options transactions. To learn more, see our Fee Schedule, Order Flow Rebate FAQ, and Order Flow Rebate Program Terms & Conditions. Options can be risky and are not suitable for all investors. See the Characteristics and Risks of Standardized Options to learn more. All investing involves the risk of loss, including loss of principal. Brokerage services for US-listed, registered securities, options and bonds in a self-directed account are offered by Open to the Public Investing, Inc., member FINRA & SIPC. See public.com/#disclosures-main for more information.

In this video, we'll perform a PFE stock analysis and figure out what Pfizer looks like based on the numbers. Is Pfizer stock a buy?

Jim Cramer killed $NVDA Bitcoin - buy now? $PFE in to GLP 1 - be careful $LLY and $NVO are the buys $C is a buy here $ONON - Motley Fool finally says buy $RCL - $TJX $WMT - BUYS $EXPE - may be a good one to get to gap fill on a pullback $MU earnings $XLU and $XLC - how to play these buys in the algorithm ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEEKING ALPHA PREMIUM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  - save up to 20% plus a FREE 7 day trial ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for ALPHA PICKS here - SAVE $50. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ SIGN UP FOR TRENDSPIDER AND GET ALL OF THESE 1) My 4 hour algorithm 2) 65 Min algorithm to day trade with 3) Custom watch lists  4) Custom Scanners to find entries  TRENDSPIDER SALE - best offer available (limited time)  Sign up at the top link ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/dailystockpick ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (use code DSP25 if prompted) Email me at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠dailystockpick3@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  I'll send you all the algorithms, watchlists and scanners that you see me use each and every day.  Social Links and more - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/dailystockpick⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  FREE NEWSLETTER WITH CHARTS - subscribe at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠dailystockpick.substack.com ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠SPONSORED BY VISIBLE - Check out this page - $20 off your first month - only $5 for the first month ⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for Webull and get free stocks like I did ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get AT&T Fiber at your home - I have 1GB service ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.att.com/referral/code/?ref=TVY-3964⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  --- Send in a voice message: https://podcasters.spotify.com/pod/show/dailystockpick/message

On this week's Biotech Hangout, hosts Eric Schmidt, Josh Schimmer, Dawn Bell, Brad Loncar, Tim Opler, Sam Fazeli and Paul Matteis kick off the show by discussing CPI data and how inflation is impacting the $XBI, with analysts hopeful that stability will bring lower interest rates soon. The hosts cover the obesity market, providing updates on new datasets, such as findings from $LLY and $NVO, which indicate promising results in liver fat reduction and potential fibrosis reversal with GLP1+ agents. They also discuss competitive dynamics and investor sentiment of the obesity market and highlight the involvement of various players, including new startups and established pharma companies. In addition, the hosts share updates on Alzheimer's treatments, including takeaways from the EULAR meeting and $LLY's lecanemab panel, alongside the competitive landscape between $LLY, $ESAIY and $BIIB. The hosts also explore the role of patient advocacy within the biotech industry, focusing on $PFE's DMD study and $SRPTA's upcoming PDFUA, the role that patient advocacy groups have on regulatory decisions,  and the impact these groups have on influencing industry standards and guidelines. *This episode aired on June 14, 2024.

Tom Vice is the CEO of Sierra Space, a company that's trying to build an economy in low-Earth orbit (LEO), a mere 250 miles above our heads. Ricky Mulvey caught up with Vice for a conversation about the future of space commercialization. They discuss: - The magic of microgravity, and its impact on everything from biotech and batteries to chemistry and computing. - Rent in low-Earth orbit. - Defense systems and the hope of a space-based “McDonald's Effect.” Companies discussed: MRK, PFE, MRNA, NVDA Host: Ricky Mulvey Guests: Tom Vice Producer: Mary Long Engineer: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode unveils the chilling reality of a counterfeit crypto app on the Apple App Store and the shocking mass extortion by Incognito Market. Discover the cunning world of "wallet drainers," the fallout of an audacious exit scam, and the stark reminder of the darknet's treacherous terrain. For anyone intrigued by the intersections of cybersecurity, digital ethics, and the ever-evolving landscape of online threats, this narrative is a must-listen. Original Articles: The Case of the Counterfeit Crypto Keeper: https://www.bleepingcomputer.com/news/security/fake-leather-wallet-app-on-apple-app-store-is-a-crypto-drainer/ The Incognito Market Meltdown: https://krebsonsecurity.com/2024/03/incognito-darknet-market-mass-extorts-buyers-sellers/ Thanks to Jered Jones for providing the music for this episode. https://www.jeredjones.com/ Logo Design by https://www.zackgraber.com/ Tags: crypto heists, digital deception, Apple App Store scams, wallet drainers, darknet markets, Incognito Market, extortion tactics, cybersecurity, cryptocurrency scams, online security, digital ethics Search Phrases: How to avoid crypto scams on the Apple App Store What are wallet drainers and how do they work Latest news on darknet market scams Understanding extortion tactics in cybersecurity Incognito Market exit scam and extortion scheme Tips for enhancing online security and avoiding scams Cryptocurrency scams and how to protect yourself The impact of digital deception on cybersecurity Exploring the ethics of digital practices and security measures Navigating the complexities of cryptocurrency and darknet markets Transcript: Mar 12 [00:00:00] announcer: Welcome to The Daily Decrypt, the go to podcast for all things cyber security. Get ready to decrypt the complexities of cyber safety and stay informed. Stand at the frontier of cyber security news, where every insight is a key to unlocking the mysteries of the digital domain. Your voyage through the cyber news vortex starts now. [00:00:29] offsetkeyz: All right. Welcome back today, we're untangling the web of a counterfeit crypto app. Mimicking leather wallet. That's picking pockets in the virtual vault of the apple store. Oh, and when you thought your digital dealings were dark enough, incognito market decides to exit stage left with a grand finale. That turns extortion. Into an art form. [00:00:52] transition: Thanks for watching! [00:00:58] offsetkeyz: Red leather wallet, yellow, [00:01:00] leather wallet, red leather wallet, yellow leather wallet. All right. So let's dive into the case of the counterfeit crypto keeper. There was a new up and coming crypto wallet, service named. Leather wallet. That though is a real. Website and can really store cryptocurrencies. They do not have an app on the apple store. They're developers have tweeted. They have sent out emails. They've let their users know that there is no app on the apple store at this time yet. There is an app. Named leather wallet on the apple store. So as you might have guessed, this app is a counterfeit app that is just trying to get your real cryptocurrency out of the real leather wallet. Service. This counterfeit app is one of many. What's known as. Wallet drainer apps. There are malicious applications or scripts that deceive users into entering their secret passphrases or executing harmful transactions. These apps allow attackers to steal digital [00:02:00] assets, including cryptocurrencies and NFTs from users, wallets. This past year, we've seen a significant increase in crypto drainers. With the tackers hacking social media accounts with large followings. In order to promote fishing sites or taking out ads to direct users, to malicious sites. So if you are a user, a customer of leather wallet, And you have entered your passphrase into the fake app? Well, any app because the company doesn't have an app. The company is advising you to transfer your cryptocurrency to a new wallet as soon as possible. The real leather wallets website is just leather.io. So make sure that any apps you download in the future are from that website directly. The fraudulent app still remains available on the app store as of today. And it was last reported as still active, published under Leetal calm Ru. So a jumble of characters. And has a 4.9 rating. Uh, though, most of the reviews seem to be fake. [00:03:00] Um, it's pretty impressive that these scammers have gotten these apps onto the apple app store. I mean, there's tons of apps. That's, it's hard to review them all. But apple usually has a good reputation for reviewing these. I'd love to see a specific policy at apple for any sort of banking or. Cryptocurrency, app's going through a little extra scrutiny. Perhaps reaching out to the official company before approving the app. I know cryptocurrency is becoming more and more consumer, but. The best practice here is to navigate to the website. That you. Have your cryptocurrency in make sure it's the actual website. Like I mentioned before. These scammers can purchase Google ad space and advertise a fake website that would link you to their app. So make sure it's not an advertisement for the website. Make sure it's the real website. And find the download links there. I know that it adds an extra step. From just. Searching the app store for the name, but. The stakes are pretty high with [00:04:00] your cryptocurrency. [00:04:06] offsetkeyz: Our second story comes from Krebs on security, and it is a story about betrayal. Blackmail. And the digital underworld that could send shivers down your spine. All right. So there is a market on the dark web, and if you haven't heard my talk on the dark web, it was released last Sunday, live talk. That should give you some context for this. There is a market called the incognito market. Which is a notorious dark net narcotics. Bizarre. Known for its anonymity and a thriving underground marketplace. Having built up a rapport with the criminals and drug dealers of the dark web, the incognito market has started. Extorting, both its buyers and its vendors threatening to release their cryptocurrency transaction details in chat records. Unless they PFE ranging from $100 to $20,000. This [00:05:00] extortion is following. What's called an exit scam that recently took place on the incognito market, where the users of this market found themselves unable to withdraw millions of dollars worth of funds. Which indicates that this platform shut down very abruptly. Now they've released this blackmail message on the home page that warns users. Of the impending release of 557,000 orders and 862,000 cryptocurrency transaction IDs. Unless they comply with the extortion demands. So obviously this market is done for. Their reputation is completely tarnished. They will never come back. But they're trying to take down everybody with them. This is one of the risks of the dark web and doing illegal things there. Because once you start dealing in illegal trades, You have something that you want to keep private and they know that something. And anything you want to keep secret can be extorted. Brett Johnson, a reformed cybercriminal comments that all darknet markets eventually end in [00:06:00] exit scams or law enforcement shutdowns. Which is highlighting a pattern of unreliability and deceit inherit. To such platforms. Knowing that every marketplace will end in either. An exit scam or law enforcement, neither of which are appealing. Yet, they still give their money to these markets and do their business there. It tells me yes, that the reward outweighs the risk. But it is a slight defender when that we need to lean in on. On this inconsistency. And we got to keep going. We got to keep disrupting these markets. And that's all we have for the day. Thanks so much for listening. We hope you enjoyed this shorter episode. [00:06:44] offsetkeyz: And we will be back tomorrow. With some more news. [00:07:00]

Jeffrey Mosher welcomes Carlos Martinez, new President for People First Economy, Grand Rapids, MI. 1. Carlos, what drew you to this leadership with the People First Economy (PFE) team, and how did you get interested in furthering sustainable economic development in Michigan? 2. What past work and lived experiences are you bringing to the PFE team when it comes to your role as President? 3. How has the internal transition from former PFE President, Hanna Schulze, to you as the new President been over the past month? 4. How does PFE plan to garner relationships in Michigan to strengthen its reach statewide? 5. What should Michigan business leaders and aspiring business owners know about PFE should they be interested in getting involved with the PFE team? 6. Could you tell me a bit more about PFE's Thursday, February 29th annual meeting and how listeners can get involved? » Visit MBN website: www.michiganbusinessnetwork.com/ » Subscribe to MBN's YouTube: www.youtube.com/channel/UCqNX… » Like MBN: www.facebook.com/mibiznetwork » Follow MBN: twitter.com/MIBizNetwork/ » MBN Instagram: www.instagram.com/mibiznetwork/

S&P Futures are slightly lower this morning. PFE, JBLU, GM& DHR all reported beats this morning. After the bell today, MSFT, GOOG, SBUX & AMD are scheduled to report. After the close yesterday, AI darling SMCI delivered positive earnings with strong guidance. The FOMC meeting starts today with an announcement scheduled for tomorrow afternoon on monetary policy. In Europe, stocks are higher with earnings reports helping to push indexes higher this morning. Oil prices are flat, but have been trending lower in the pre-market, Aramco said it had been ordered by the Saudi government to keep its oil production capacity at 12 million barrels a day.

Pat kicks off the show talking about odd street names, what street did you grow up on? Do you know what PFE stands for? and more....

Tracey Ryniec and John Blank examine whether a recession is looming and how to invest in the new year. (1:30) - Breaking Down The Economy Heading Into The End of The Year (10:00) - Is The Slow Down Here With People Having A Hard Time Finding Jobs? (16:30) - Using Economic Data To Understand What Is Happening Within Industries (24:00) - John Blanks Top Picks To Keep On Your Radar (30:10) - What Are Some Other Areas Your Should Have On Your Watchlist For 2024? (39:30) - Episode Roundup: SIG, ULTA, SAIC, HALO, ANTE, LLY, PFE, ALB Podcast@zacks.com

In this video, we'll perform a PFE stock analysis and figure out what Pfizer looks like based on the numbers. We'll also try to figure out what a reasonable fair intrinsic value is for Pfizer. And answer is Pfizer one of the best stocks to buy at the current price? Find out in the video above! Global Value's Pfizer stock analysis. TIKR is the website I use for financial data in my videos. Join me and thousands of investors worldwide by using TIKR in your investment analysis. All funds from referrals directly support the channel to improve video quality! Referral link - https://www.tikr.com/globalvalue Check out Seeking Alpha Premium and score an exclusive $50 off coupon plus a free 7 day trial! All funds from affiliate referrals go directly towards supporting the channel! Affiliate link - https://www.sahg6dtr.com/H4BHRJ/R74QP/ If you'd like to try Sharesight, please use my referral link to support the channel! https://www.sharesight.com/globalvalue (remember you get 4 months free if you sign up for an annual subscription!) Discover new investing resources and directly support the channel by shopping my Amazon storefront! All commissions are reinvested to improve the quality of videos! https://www.amazon.com/shop/globalvalue Pfizer ($PFE) | Pfizer Stock Fundamental Analysis | Pfizer Stock Dividend Analysis | Pfizer Dividend Analysis | $PFE Dividend Analysis | Pfizer Fair Value | PFE Intrinsic Value | PFE Fair Value | Pfizer Intrinsic Value | Pfizer Discounted Cash Flow Model | Pfizer DCF Analysis | PFE Discounted Cash Flow Analysis | PFE DCF Model #Pfizer #PFE #Pfizerstock #PFEstock #stockmarket #dividend #stocks #investing #valueinvesting #dividendstocks #investor #valueinvestor #stockanalysis #dividend #dividends #dividendstocks2023 #pharmastocks (Recorded November 20, 2023)

A proposed merger between Alaska Airlines and Hawaiian Airlines could help Alaska take market share over time. (00:21) Jason Moser and Deidre Woollard discuss: - The possibility of the Alaska Airlines and Hawaiian Airlines deal going through. - If airlines lose specialness as they grow. - The race to bring GLP-1 drugs to market. (18:35) Deidre Woollard chats with Solo Brands CEO John Merris about the company's collection of brands and where it could be headed next. Companies discussed: HA, ALK, AMZN, DTC, PFE, RHHBY Claim your dividend stocks here: www.fool.com/dividends Host: Deidre Woollard Guests: Jason Moser, John Merris Producer: Mary Long Engineers: Dan Boyd, Desiree Jones Learn more about your ad choices. Visit megaphone.fm/adchoices

Did you buy at the pandemic highs and now your stock is in the red? What to do now. (1:30) - What Should You Do With Your Big Loser Stocks? (6:10) - Learning From Microsoft's Long Term Performance (13:30) - Strong Growth Stocks That Have Been Beaten Down: Should You Be Buying? (25:00) - Will PayPal Rebound Anytime Soon? (33:20) - Can The Pandemic Stock Winners Make A Comeback? (47:30) - Episode Roundup: MSFT, SHOP, TWLO, PYPL, PFE, PINS, MELI, NVDA

S&P Futures are displaying positive action this morning. Earnings data overnight came in positive and no change in monetary policy is expected from the Fed tomorrow. In fact, the expectation is that Powell will indicate that a rate hike this year is very unlikely. China's PMI data came in weaker than expected and the Bank of Japan was not as hawkish as expected in its monetary policy statement last night. After the bell today, earning reports from AMD, CZR, MTCH & PAYC are due out. This morning we have beats from CAT & PFE. In Europe, Equities are mostly higher ahead of inflation and GDP reports and oil prices are rebounding this morning with pending stockpiles reports set to be released after the close and tomorrow morning.

S&P Futures are showing strong gains this morning ahead of an important week for the markets. Key earning reports from CAT, AMGN, PFE, AMD, HUM, QCOM, LLY & AAPL are due out this week. This morning we have beats from MCD, L and XPO. FOME announcement is Wednesday and on Friday the market will react to the Non Farm payrolls report for October. In Europe, Equities are mostly higher and oil prices falling as the Middle East conflict remains contained.

In episode 61 of Derms and Conditions, our host, James Q. Del Rosso, DO, presents a self-made episode where he clarifies key points on many therapies relevant to every-day clinical practice. First, he discusses topical alpha-agonist therapy for persistent facial erythema (PFE) of rosacea. Long-term data shows that daily use of either topical oxymetazoline or brimonidine appears to “reset” (lower) the baseline level of PFE in patients with rosacea.  Next, he talks about sub-antibiotic dosing of doxycycline and how its anti-inflammatory properties, including support of the dermal matrix, can be used for the treatment of rosacea. He notes that studies have demonstrated reduced antibiotic selection pressure with decreased emergence of antibiotic-resistant bacterial strains with this therapeutic approach. Additionally, monotherapy with sub-antibiotic dose doxycycline used as maintenance treatment has been shown to be effective in reducing relapse of papulopustular rosacea (PPR), an approach that is appealing to those patients who do not prefer or are not compliant with topical therapy. Dr. Del Rosso then mentions sarecycline, a narrow-spectrum tetracycline FDA-approved for the treatment of acne in patients > 9years of age, which has also been shown in a large pilot study to be effective for PPR. Microbiological data demonstrates that the narrow antibiotic spectrum of sarecycline spares activity against many strains of bacteria, especially gram-negative organisms that inhabit the GI tract. He then transitions to hidradenitis suppurativa (HS) and the welcome emergence of IL-17 inhibitors for HS, which are very effective based on study results to date. Dr. Del Rosso stresses the importance of early consideration of biologic therapies (such as anti-IL agents) for HS as this disease progresses below the skin surface with eventual development of sinus tracts and scarring. If we wait until we “see” these consequences, it is too late as they have already occurred. FDA approvals and published guidelines typically depend on visibly seeing the clinical manifestation before a specific therapy is recommended, which is not early enough in many cases. He finishes with a discussion on dupilumab for the treatment of atopic dermatitis, which is often remarkably effective, but at times may be limited by partial efficacy or side effects such as conjunctivitis and facial erythema. Dr. Del Rosso discusses practical use of JAK inhibitors, such as abrocitinib and upadacitinib for AD in dupilumab “non-responders”, and also case reports with tralokinumab, a monoclonal antibody targeting IL-13. Tune in to this episode to learn more!

Who else is holding on to their skinny jeans for dear life?! Some of us over here aren't ready to give them up, including today's guest, Sara Whittaker of Podcasting for Educators. We're getting into all the millennial memories - emo music, burning the perfect CD, TRL, choreographed dances…the list goes on. Plus, you'll hear how Sara went from a classroom teacher to virtual assistant to podcast manager. Sara Whittaker is a teacher turned podcast strategist. She helps educators leverage the power of podcasting in order to scale their business and connect with their audience. Sara is also the host of the podcast, Podcasting for Educators, where she shares weekly tips on how to start, manage, and grow a podcast. Today's Banter: Finding the PERFECT water bottle The battlefield that is the Aldie egg section The way that songs hit back in the day (and the memories that still come back when we hear them) Exploiting our family computers to viruses via Limewire Can we get a pulse check on Brittany Spears? Rebecca gets broken up with before prom Bestie Banter includes: blood boilers, little luxuries, and millennial memories Business Banter: Transitioning from teaching to entrepreneurship, niching down to a specific client, growing a team, and more Links You May Be Looking For: Rebecca's Instagram: @themomfluencer Lauren's Instagram: @counselorclique Rebecca's Amazon Storefront Lauren's Amazon Storefront $20 off your first Nuuly box! Set up your Facebook ads consult call with Numbers Drive! Sara's Instagram: @podcastingforeducators PFE website Podcasting for Educators podcast Angsty Millennial Mom Music Pre-Prom Pump Up Playlist Gel eye patches Owala water bottle The Podcasting for Educators Prep-School - use code BESTIE for $50 off! The Live Free Academy - start your freelance business!

S&P Futures are starting off the month of August in the red. Weakening PMI data from China and Europe is creating a negative sentiment this morning. CAT &PFE reported better than expected earrings. BP & MRK missed estimates. This afternoon AMD, SBUX, ALL,& PINS are scheduled to release. Market will be focused on the ISM Manufacturing report due out this morning, In Europe, the major indexes are down on weaning retail sales data out of the U.K and disappointing PMI data in the E.U. Oil prices are lower as traders appear to be booking profits ahead of an uncertain demand outlook.

Welcome to the latest episode of PFE, your one-stop podcast for all things NFL! In this week's exciting installment, we dive into the hottest topics gripping the football world. Join your hosts, Justin and Zayne, as they bring you up to speed with the latest NFL updates, explore the much-anticipated release of Madden 24, and reveal their expert insights into the fantasy running back rankings.Segment 1: NFL UpdatesWe kick off the episode with a rundown of the most recent NFL updates, discussing the latest roster changes, trades, and injuries impacting teams across the league. From high-profile quarterback transfers to breakout stars making their mark, we analyze how these developments might influence the upcoming season's dynamics and shape the playoff landscape.Segment 2: Madden 24 - A New Era BeginsThe gaming world is buzzing with excitement as Madden 24 hits the shelves. In this segment, we take an in-depth look at Madden player ratings and comments around the league!Segment 3: Fantasy Running Back RankingsFor all the fantasy football enthusiasts out there, this is the segment you've been waiting for. Our hosts analyze and debate their top running back picks for the upcoming fantasy season. Drawing on expert analysis, player performance history, and potential breakout candidates, they provide valuable insights to help you gain the edge in your fantasy league. Whether you're a seasoned fantasy player or new to the game, you won't want to miss this section.ConclusionTune in to PFE for a podcast that delves deep into the world of NFL updates, video game excitement with Madden 24, and the strategic world of fantasy running back rankings. Don't miss this action-packed episode that's sure to leave you eagerly awaiting the next installment!Support the show

O programa Desenrola já começou a operar ontem e a próxima etapa já está definida: vai contemplar dívidas de luz, telefone e carnê de lojas varejistas. Agora o governo trabalha para garantir a adesão do Nubank. O programa é tema do 5 minutos de hoje (18). Ainda neste episódio: aumenta racha no PP, casal acusado de agredir Alexandre de Moraes presta depoimento à PFe a despedida de João Donato. Aqui você encontra, em nossos programas, os bastidores do poder e análises exclusivas.  Assine o combo O Antagonista + Crusoé  https://bit.ly/assineoantagonista Inscreva-se e receba a newsletter:  https://bit.ly/2Gl9AdL Você pode entrar em contato conosco pelo e-mail:  assinante@oantagonista.com Confira mais notícias em nosso site:  https://oantagonista.uol.com.br/ https://crusoe.uol.com.br/ Acompanhe nossas redes sociais:  https://www.fb.com/oantagonista​ https://www.twitter.com/o_antagonista ​https://www.instagram.com/o_antagonista https://www.tiktok.com/@oantagonista_oficial No Youtube deixe seu like e se inscreva no canal: https://www.youtube.com/c/OAntagonista

As loans get more expensive, what are the ripple effects for start-up companies in the tech industry? (00:21) Bill Mann discusses: - Uber's 1st-quarter results and CEO Dara Khosrowshahi's declaration of profitability in 2023 - Pfizer's results beating expectations despite demand for its Covid vaccine is falling - Why he's more interested in the Federal Reserve on Wednesday than the jobs report on Friday (10:49) Alison Southwick and Robert Brokamp continue their conversation with Bill Mann about how the "new normal" is affecting the tech industry in Silicon Valley. Investments discussed: UBER, PFE, MRK, AAPL Host: Chris Hill Guests: Bill Mann, Alison Southwick, Robert Brokamp Producer: Ricky Mulvey Engineers: Dan Boyd, Rick Engdahl

VIDEOS: EXCLUSIVE: UNDERTAKER EXPLAINS “MYSTERIOUS” CLOTTING PHENOMENON! | Louder with Crowder (part 2) Society is going to COLLAPSE -Neil Oliver ( 5:24) Fear Psychosis and the Cult of Safety – Why are People so Afraid?  – Academy of Ideas (13:25)   Dietary supplement found to improve concentration levels University of Granada, November 3, 2022 The research group from the University of Granada (UGR) has tested the effects of a multi-ingredient dietary nootropic on concentration levels and cognitive performance. Nootropics are cognitive enhancers that have traditionally been used in the treatment of cognitive pathologies. Leading this study was Lucas Jurado Fasoli—a researcher from the Scientific Unit of Excellence in Exercise, Nutrition and Health (UCEENS) at the Sport and Health Joint University Institute (iMUDS). He explains that, traditionally, nootropics have been drugs, with their corresponding side-effects. “To address the issue of potential side-effects, different dietary nootropics have emerged as an alternative way to enhance cognitive performance. And these, as is the case in this study, are used by healthy individuals in activities such as preparing for competitive exams or video-game competitions,” explains Jurado Fasoli. The results of the study showed that the acute intake of this multi-ingredient nootropic decreases the response time across different cognitive tests: in processing speed, inhibitory control, working memory, and cognitive flexibility. It also increases accuracy in tests involving processing speed, inhibitory control, and cognitive flexibility. The supplement contains L-tyrosine, acetyl L-carnitine, sodium citicoline, alpha-GPC, taurine, caffeine, mango leaf extract and huperzia serrata leaf. These results were accompanied by an increase in positive emotions and a decrease in negative emotions and depression. And, importantly, the favorable effects of this nootropic did not appear to have any effect on the heart-rate of participants. Previous studies have shown that supplementation with the combination of caffeine and taurine, L-theanine, tyrosine, and mango leaves extract can improve the RT in different cognitive and computerized tests. In this study, we showed that a dietary multi-ingredient nootropic improves the processing speed of information in young healthy adults. This effect could be due to the synergic effects of different dietary ingredients included in the nootropic. Also, it could be partially explained by the central nervous system activation and alertness enhancement effect of caffeine, which could increase the processing speed and decrease the RT. The inclusion of L-theanine as a dietary ingredient in the nootropic counteracts the potential effects derived from a high dose of caffeine on anxiety, psychological stress, blood pressure, and HR, which completely agrees with our results. A sample comprising 26 young adults (50:50 male/female, with an average age of 25) participated in the study. They were required to undertake various cognitive tests twice, separated by 48 hours, having ingested either the multi-ingredient dietary nootropic or a placebo (randomized and triple-blinded across the sample). Thirty minutes after ingestion, measurements were taken of processing speed, inhibitory control, working memory, cognitive flexibility, creativity, and verbal fluency. Different emotions were also evaluated and the participants' heart-rate was recorded while they undertook the tests. Consuming more magnesium associated with lower risk of mortality during years following heart attack Wageningen University and Research (Netherlands), October 31, 2022 A study of people with a history of heart attack found that those who consumed more magnesium lived longer than those whose intake was low. Having a high magnesium intake, defined as greater than 320 milligrams (mg) per day, was associated with a 28% lower risk of dying from cardiovascular disease and a 22% lower risk of death from any cause compared to a low intake, defined as less than 283 mg per day. The protective effect of magnesium was even stronger in patients who were being treated with diuretic drugs. In this group, the risk of mortality from cardiovascular disease was 45% lower among those with high magnesium compared to those with low magnesium. “Little is known about magnesium intake and long-term mortality risk in cardiovascular disease patients,” authors Ilse Evers and colleagues noted. “Magnesium requirements may be different in cardiovascular disease patients because of alterations in the cardiovascular system, comorbidities and/or medication use.” The study included 4,365 participants in the Alpha Omega Cohort, an ongoing follow-up of participants in the earlier 40-month Alpha Omega Trial. The Alpha Omega Trial included men and women between the ages of 60 and 80 years who had experienced a heart attack within 10 years prior to enrolling between 2002 and 2006. Dietary questionnaire responses obtained at enrollment provided information concerning magnesium intake from food and non-food sources. Mortality was ascertained through 2018. The findings were published in Frontiers in Cardiovascular Medicine. Calorie restriction promotes longevity through effects on mitochondrial network Harvard School of Public Health, October 27 2022. Research reported in Cell Metabolism helps explain the effects of calorie restriction and activation of AMP-activated protein kinase (AMPK, an energy-sensing protein) on longevity. Harvard researchers have determined that AMPK and calorie restriction promote homeostasis and plasticity of networks formed by the cells' power plants known as mitochondria. Mitochondria networks change shape according to energy demand, however, this ability declines with age. “Dynamic remodeling of mitochondrial networks by fusion and fission promotes maintenance of cellular homeostasis,” explain Heather J. Weir and colleagues at the Harvard T. H. Chan School of Public Health. “Dysregulation of mitochondrial dynamics and aberrant mitochondrial morphology are hallmarks of aging and are thought to contribute to the pathology of numerous age-related pathologies including Alzheimer's and Parkinson's disease.” By restricting calories in the diet of roundworms or using a strain of roundworm in which an AMPK subunit is activated, the researchers found that the roundworms maintained a youthful fused mitochondrial network shape with age. The youthful networks lengthen life by communicating with peroxisomes within the cells to alter fat metabolism. “Low-energy conditions such as dietary restriction and intermittent fasting have previously been shown to promote healthy aging,” Dr Weir commented. “Our work shows how crucial the plasticity of mitochondria networks is for the benefits of fasting. If we lock mitochondria in one state, we completely block the effects of fasting or dietary restriction on longevity.” Electroacupuncture found to ease nausea and vomiting in ICU patients recovering from chemotherapy Narbonne Hospital (France), October 28, 2022 Refractory vomiting is just one of many complications endured by patients confined to intensive care units (ICU) due to chemotherapy and other major medical treatments. But relief may be coming in the form of transcutaneous electroacupuncture (TEA) therapy that can alleviate the worst symptoms of persistent vomiting. Earlier studies have shown that TEA can reduce episodes of nausea and vomiting attributed to chemotherapy treatments, recently concluded medical operations, and pregnancy. It is growing popular as an alternative to anti-emetic medication. The TEA treatment consisted of two electrodes attached on either side of the Neiguan (PC 6) pressure point, also known as the pericardium meridian. The researchers employed a standard neuromuscular transmission monitor to stimulate the acupuncture point for 30 minutes. The overall incidence of nausea or vomiting within the first 24 hours after TEA was 50 percent. After the 24-hour mark, 30 percent of the patients perceived nausea, and 20 percent experienced vomiting. Ninety percent of patients reported suppression of nausea/vomiting immediately after undergoing TEA. During a six-hour period after TEA, 60 percent of patients did not sense nausea or experience vomiting. Between six to 24 hours after TEA, 60 percent of patients remained free from nausea or vomiting episodes. Two patients who experienced nausea were given a second TEA session that remedied all symptoms.TEA itself was free from any complication and side effects. The Mindfulness Skill That Is Crucial for Stress A new study suggests that practicing acceptance helps reduce our stress more than simple mindful awareness. Carnegie Mellon University, October 28, 2022 In this study, researchers randomly assigned 137 stressed adults of various ages and ethnicities to one of three programs: an eight-week Mindfulness-Based Stress Reduction (MBSR) course, where they learned to mindfully pay attention to their present-moment experiences in an accepting, nonjudgmental way; an MBSR course without instructions on acceptance; or no course. The courses included many lessons—for example, how to pay attention to your breath and your body sensations, and how to eat food or take a walk mindfully—as well as practice time outside of class. Before, during, and afterwards, participants reported five times daily about how stressed they felt in the moment and whether they'd experienced a stressful event since their last report.In response to stress, many people today are turning to meditation or mindfulness apps (myself included). But not all mindfulness practice is equally effective for combating stress, a new study suggests. It's possible that some of our practices may be missing a vital ingredient: acceptance. Though all of the groups experienced less stress and fewer incidents of feeling stressed over time, the people who took the full MBSR course had a significantly steeper improvement than the other two groups. “Learning how to accept your present-moment experience is really important for reducing stress,” says Emily Lindsay, one of the study's coauthors. “It seems to be a key element of mindfulness training.” Mindfulness practices that specifically emphasize acceptance teach us a nonjudgmental attitude toward our experiences—meaning, learning not to label our thoughts, feelings, or experiences as good or bad, and trying not to change or resist them in any way. While many mindfulness courses include instructions in acceptance as par for the course, those that don't may not be as effective. People who learn to accept and not just notice their experiences become less prone to mind-wandering, which has been tied to well-being, and less reactive to stress—meaning, they show reductions in systolic blood pressure, the stress hormone cortisol, and feelings of stress in a stressful situation. Her recent study adds to these results by monitoring participants daily, helping to show that acceptance makes a difference in everyday life situations and not just in the laboratory. Accepting stress helps people to stop focusing only on what's wrong and to notice other feelings, sensations, and thoughts occurring at the same time, enabling them to see the “bigger picture.” Acceptance is not about acquiescing to your fate, though —like getting a diagnosis of a terminal illness and just accepting that you're going to die. That kind of “acceptance” leads to worse outcomes. Nor is it about accepting poor treatment from other people. It's more about accepting your internal experience—your thoughts and feelings—which informs you about how to respond to your external circumstances in a wiser way. For example, if you feel angry and accept your anger in the moment, it may prevent you from lashing out at someone and help you see that your feelings aren't their fault Eat more trifoliate oranges to keep your prostate healthy Korean Institute of Oriental Medicine, October 26, 2022 Compared to younger individuals, older men are at a higher risk of developing benign prostatic hyperplasia (BPH) or an enlarged prostate. A study published in the journal BMC Complementary and Alternative Medicine reveals a compelling reason for men to eat trifoliate oranges, as extracts from the fruit were proven effective in preventing the onset of BPH and cease its progression. The trifoliate orange (Poncirus trifoliata), also known as the hardy orange, is a citrus fruit native to China. It is grown in parts of the US and Europe for use in jellies, marmalades, and jams despite its notoriously bitter taste. It has been used as an ingredient in Traditional Chinese Medicine since ancient times, and current studies have shown its importance in maintaining prostate health. As the word “benign” in its name implies, BPH is relatively harmless. In fact, some consider it a normal part of the aging process among males. It can, however, be extremely inconvenient as its symptoms can make the vital act of urinating difficult. It can also cause a constant feeling of needing to pee even at night; in most cases, sufferers may find themselves unable to sleep properly because of this particular symptom. The researchers in the aforementioned looked at the trifoliate orange as a possible treatment for BPH. In particular, the study investigated the extract from Ponciri Fructus (PFE), the young fruit of the trifoliate orange, and its protective effects on the development of the BPH. In the study, the researchers induced BPH in a rat model by injecting testosterone propionate (TP) and corn oil every day for four weeks. PFE was administered via oral gavage at a dose level of 200 mg/kg, one hour before these injections over the same duration. At the end of the study, the rats were sacrificed and examined for markers of BPH. Specifically, the researchers took note of relative prostate weight, the levels of testosterone and dihydrotestosterone (DHT), common factors influencing the development of BPH. At the end of the study, the researchers noticed reductions in relative prostate weight, the level of testosterone and DHT in serum and prostatic tissue, prostatic hyperplasia, and the expression of PCNA. They also noted higher levels of antioxidant enzymes.

Halfway through 2022 it's time for investors to see where we've been and what to look for in the 2nd half of the year. (0:30) Ron Gross and Jason Moser discuss: - Investing headlines for the 1st half of the year - Early frontrunners for "CEO of the Year" - Who needs a stronger 2nd half of 2022 - 3 stocks poised for upside (19:00) We're dipping into the vault for one of our favorite conversations. Recorded in front of a live audience, best-selling author David Epstein discusses Tiger Woods, predictors of success in the business world, and other takeaways from his book Range: Why Generalists Triumph in a Specialized World. Our free investing starter kit includes research on 15 stocks and 5 ETFs. Get a copy by going to http://fool.com/starterkit Stocks discussed on the show: PFE, TTD, SBUX, TWTR, TGT, DIS, NFLX, DOCU, ADBE, MSFT, ZM, MAR, ABNB, UBER Host: Chris Hill Guests: Jason Moser, Ron Gross, David Epstein Engineer: Dan Boyd